Skip to content

Electrical contrastimulation on the calf for Restless Legs

Electrical contrastimulation on the calf for Restless Legs

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27456
Enrollment
12
Registered
2019-04-09
Start date
2019-10-02
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restless Legs Syndrome

Interventions

Subjects are instructed to use LEX0 for 4 weeks in home environment for their restless legs, as needed. An user manual is handed. In the event of an RLS attack, LEX0 is placed with the electrode patch

Sponsors

Relegs
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - age >18 < 80 yrs; - 5 essential diagnostic criteria RLS according IRLSSG; - RLS attack = once a week. IRLSSG: International Restless Legs Syndrome Study Group

Exclusion criteria

Exclusion criteria: - RLS medication - Cardiac pacemaker, Implanted defibrillator, Transdermal drug delivery system - Open wounds, skin eruptions or infected areas on legs - Lack of normal sensation in legs - Deep vein thrombosis during last 6 months - Another sleep disorder - Another movement disorder (e.g. Parkinson disease, dyskinesia, or dystonia) - Epilepsy - Pregnancy

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale on RLS symptoms (VAS).

Secondary

MeasureTime frame
RLS severity (IRLS), Sleep (MOS-sleep), Quality of Life (RLS-QoL) and Safety (Registering adverse reactions and serious adverse events).

Contacts

Public Contactcasper van waveren Hogervorst

Centrum Oosterwal

c.vanwaverenhogervorst@centrum-oosterwal.nl0619626021

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)